-transparent.png){kind=logo}
We studied six oliguric patients with rhabdomyolysis-induced acute renal failure. On admission, all had marked hyperphosphatemia and hypocalcemia associated with low levels of 1,25-dihydroxycholecalciferol [1,25(OH)2D]. During the early polyuric phase, moderate hypercalcemia was accompanied by marked elevations in plasma 1,25(OH)2D and persistent elevations in parathyroid hormone (both amino and carboxy terminals). During the late polyuric phase, the levels of serum calcium and 1,25(OH)2D reverted to normal. Thus, in rhabdomyolysis-induced acute renal failure, the hypocalcemia of the oliguric phase may be secondary to decreased synthesis of 1,25(OH)2D; severe hyperphosphatemia may also have a major role. The hypercalcemia of the polyuric phase may be partly due to increased synthesis of 1,25(OH)2D, resulting from the high parathyroid hormone levels and recovery of renal function.
F Llach, and
A J Felsenfeld, and
M R Haussler
July 1972,
The Journal of biological chemistry,
F Llach, and
A J Felsenfeld, and
M R Haussler
January 1995,
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
F Llach, and
A J Felsenfeld, and
M R Haussler
March 1980,
Archives of internal medicine,
F Llach, and
A J Felsenfeld, and
M R Haussler
December 1983,
Kidney international. Supplement,
F Llach, and
A J Felsenfeld, and
M R Haussler
May 1984,
Calcified tissue international,
F Llach, and
A J Felsenfeld, and
M R Haussler
January 1978,
Nephron,
F Llach, and
A J Felsenfeld, and
M R Haussler
February 1974,
Journal of nutritional science and vitaminology,
F Llach, and
A J Felsenfeld, and
M R Haussler
September 1972,
The Journal of clinical investigation,
F Llach, and
A J Felsenfeld, and
M R Haussler
September 2003,
American journal of veterinary research,
F Llach, and
A J Felsenfeld, and
M R Haussler
September 1973,
Lancet (London, England),
